Product
BI 764198
2 clinical trials
3 indications
Indication
Chronic Kidney DiseaseIndication
ChronicIndication
HealthyClinical trial
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Assess the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Profile of BI 764198 Administered Orally Once Daily for 12 Weeks in Patients With Focal Segmental GlomerulosclerosisStatus: Recruiting, Estimated PCD: 2025-01-22
Clinical trial
A Phase I, Open-label, Two-arm, Non-randomised Trial to Investigate the Metabolism and Pharmacokinetics of a Single Dose of BI 764198 (C-14) Administered as Oral Solution Using Two Different Approaches in Healthy Male VolunteersStatus: Completed, Estimated PCD: 2023-11-09